Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | 12.29 μM | Cytotoxicity against human A549 cells assessed as cell viability after 72 hrs by MTT assay | [PMID: 23992864] |
| A549 | IC50 | 15.3 μM | Cytotoxicity against human A549 cells assessed as inhibition of cell growth after 24 hrs by MTT assay | [PMID: 25958248] |
| A549 | IC50 | 28 μM | Cell membrane permeabilization in human A549 cells assessed as drug level causing decrease in calcein fluorescence | [PMID: 19200744] |
| A549 | IC50 | 33 μM | Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction test | [PMID: 19200744] |
| Bel-7402 | IC50 | 13.2 μM | Cytotoxicity against human Bel7402 cells assessed as inhibition of cell growth after 24 hrs by MTT assay | [PMID: 25958248] |
| DLD-1 | IC50 | 38 μM | Cell membrane permeabilization in human DLD1 cells assessed as drug level causing decrease in calcein fluorescence | [PMID: 19200744] |
| DLD-1 | IC50 | 60 μM | Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction test | [PMID: 19200744] |
| ECV-304 | IC50 | 29 μM | Membrane toxicity against human ECV304 cells after 2 hrs by LDH release assay | [PMID: 24084294] |
| ECV-304 | IC50 | 29 μM | Membranolytic activity in human ECV304 cells assessed as leakage of intracellular lactate dehydrogenase after 2 hrs by spectrophotometry | [PMID: 22503361] |
| ECV-304 | IC50 | 35 μM | Cytotoxicity against human ECV304 cells after 72 hrs by Hoechst 33258 staining based fluorescence assay | [PMID: 22503361] |
| ECV-304 | IC50 | 35 μM | Cytotoxicity against human ECV304 cells after 72 hrs by MTT assay | [PMID: 24084294] |
| HeLa | IC50 | 21.18 μM | Cytotoxicity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay | [PMID: 23992864] |
| HepG2 | IC50 | 16.34 μM | Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay | [PMID: 23992864] |
| HepG2 | IC50 | 5.5 μM | Inhibition of TNF-alpha-induced NFkappaB activation in human HepG2 cells after 1 hr by luciferase reporter assay | [PMID: 21870831] |
| HL-60 | IC50 | 11.78 μM | Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay | [PMID: 23992864] |
| HL-60 | IC50 | 7.1 μg/mL | Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay | [PMID: 10514313] |
| HL-60 | IC50 | 7.1 μg/mL | Cytotoxicity against human HL60 cells by MTT assay | [PMID: 11575962] |
| L02 | IC50 | 11.5 μM | Cytotoxicity against human HL7702 cells assessed as inhibition of cell growth after 24 hrs by MTT assay | [PMID: 25958248] |
| L02 | IC50 | 20.98 μM | Cytotoxicity against human L02 cells by MTT assay | [PMID: 33964439] |
| RAW264.7 | IC50 | 1.1 μM | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitirc oxide production preincubated for 1 hr followed by LPS-stimulation and measured after 18 hrs by Griess assay | [PMID: 31301930] |
20 records · Scroll to view more